Clinical Trial Update: Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low-dose radiotherapy combined with chemotherapy and AK112 as second-line treatment for advanced gastric and gastroesophageal junction …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• AK112

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Gastric Cancer | Phase 2 | Status: RECRUITING